NASDAQ:INDV • US45579U1097
The current stock price of INDV is 32.25 USD. Today INDV is down by -0.06%. In the past month the price decreased by -6.33%. In the past year, price increased by 232.68%.
ChartMill assigns a technical rating of 5 / 10 to INDV. When comparing the yearly performance of all stocks, INDV is one of the better performing stocks in the market, outperforming 97.42% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to INDV. INDV scores excellent on profitability, but there are some minor concerns on its financial health.
On February 26, 2026 INDV reported an EPS of 0.82 and a revenue of 358.00M. The company beat EPS expectations (19.28% surprise) and beat revenue expectations (14.84% surprise).
13 analysts have analysed INDV and the average price target is 46.48 USD. This implies a price increase of 44.13% is expected in the next year compared to the current price of 32.25.
For the next year, analysts expect an EPS growth of 25.28% and a revenue growth -2.8% for INDV
Over the last trailing twelve months INDV reported a non-GAAP Earnings per Share(EPS) of 2.46. The EPS increased by 459.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.34% | ||
| ROA | 8.62% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.48 | 934.238B | ||
| JNJ | JOHNSON & JOHNSON | 20.74 | 579.34B | ||
| MRK | MERCK & CO. INC. | 22.33 | 286.278B | ||
| PFE | PFIZER INC | 8.88 | 153.814B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.46 | 122.779B | ||
| ZTS | ZOETIS INC | 16.86 | 51.259B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.84 | 26.195B | ||
| VTRS | VIATRIS INC | 5.54 | 16.304B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.14 | 11.614B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.303B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.501B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.547B | ||
| AMRX | AMNEAL PHARMACEUTICALS INC | 13.33 | 4.166B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Indivior Pharmaceuticals, Inc is a US-based company operating in Pharmaceuticals industry.
INDIVIOR PHARMACEUTICALS INC
10710 Midlothian Turnpike, Suite 125, North Chesterfield
SLOUGH VIRGINIA US
Employees: 1030
Phone: 18043791090
Indivior Pharmaceuticals, Inc is a US-based company operating in Pharmaceuticals industry.
The current stock price of INDV is 32.25 USD. The price decreased by -0.06% in the last trading session.
INDV does not pay a dividend.
INDV has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
INDIVIOR PHARMACEUTICALS INC (INDV) has a market capitalization of 4.03B USD. This makes INDV a Mid Cap stock.
INDIVIOR PHARMACEUTICALS INC (INDV) will report earnings on 2026-04-22.
You can find the ownership structure of INDIVIOR PHARMACEUTICALS INC (INDV) on the Ownership tab.